OrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.
A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and ...
The strange world of organ preservation is spawning new tech firms. OrganOx has added impetus to the industry with a $142mn ...
OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary equity financing to accelerate growth opportunities for its metra® platform ...
Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ...
OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...